A Randomized Trial of Sitagliptin and Spironolactone With Combination Therapy in Hospitalized Adults With COVID-19.

Farhad AbbasiReuben AdatorwovorMohammad Ali DavarpanahYasaman MansooriMehdi HajianiFarzan AzodiSepideh SefidbakhtShayesteh DavoudiFarzana RezaeiShayan MohammadmoradiKamyar Asadipooya

Published in: Journal of the Endocrine Society (2022)

Sitagliptin and spironolactone can potentially improve clinical outcomes of hospitalized COVID-19 patients.

Keyphrases

combination therapy
sars cov
coronavirus disease
respiratory syndrome coronavirus